ES2071004T3 - Nuevos peptidos, su uso para inhibir la maduracion de linfocitos t y la actividad de macrofagos, y procesos para su preparacion. - Google Patents

Nuevos peptidos, su uso para inhibir la maduracion de linfocitos t y la actividad de macrofagos, y procesos para su preparacion.

Info

Publication number
ES2071004T3
ES2071004T3 ES90300355T ES90300355T ES2071004T3 ES 2071004 T3 ES2071004 T3 ES 2071004T3 ES 90300355 T ES90300355 T ES 90300355T ES 90300355 T ES90300355 T ES 90300355T ES 2071004 T3 ES2071004 T3 ES 2071004T3
Authority
ES
Spain
Prior art keywords
lys
asp
arg
thr
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90300355T
Other languages
English (en)
Inventor
Istvan Dr Schon
Nee Kuprina Olga Nyeki
Lajos Dr Kisfaludy
Denes Dr Laszlo
Gyorgy Dr Hajos
Laszlo Dr Szporny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of ES2071004T3 publication Critical patent/ES2071004T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS PEPTIDOS DE LA FORMULA (1) A (20): ARG LYS (CHC) - ASP - VAL (1) ARG - LYS (CHC) - ASP (2) ARG - SAR - ASP - VAL (3) ARG - SAR - ASP (4) ORN - LYS - ASP - VAL (5) ORN - LYS - ASP (6) ARG - LYS AAD - VAL (7) ARG - LYS - AAD (8) [ ARG - LYS - ASP - NH - CH2 -] 2 (9) ARG LYS - ASP - NH - CH2 (10) [ ARG - LYS - ASP - VAL - NH - CH2 - ] 2 (11) [ ARG - LYS - ASP - CYS - NH2 ] 2 (12) LYS - SER - LYS - LEU (13) SER - LYS - LEU (14) SER - SER - SER - THR (15) LYS - GLU - THR (16) LYS - THR - GLU - THR (17) PRO - LYS - LEU - THR (18) LYS - LYS - THR - GLU (19) LYS - HIS - LEU NH2 (20) Y SU PREPARACION. LOS NUEVOS PEPTIDOS RESULTAN DE GRAN UTILIDAD PARA FINES TERAPEUTICOS, EN DONDE SE PRETENDE UNA ACCION DE SUPRESION GENERAL SOBRE LA FUNCION DEL SISTEMA INMUNE.
ES90300355T 1989-01-13 1990-01-12 Nuevos peptidos, su uso para inhibir la maduracion de linfocitos t y la actividad de macrofagos, y procesos para su preparacion. Expired - Lifetime ES2071004T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU89116A HU201964B (en) 1989-01-13 1989-01-13 Process for producing peptides inhibiting maturation of t-lymphocytes and activity of macrophages, as well as pharmaceutical compositions comprising same

Publications (1)

Publication Number Publication Date
ES2071004T3 true ES2071004T3 (es) 1995-06-16

Family

ID=10948008

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90300355T Expired - Lifetime ES2071004T3 (es) 1989-01-13 1990-01-12 Nuevos peptidos, su uso para inhibir la maduracion de linfocitos t y la actividad de macrofagos, y procesos para su preparacion.

Country Status (12)

Country Link
US (1) US5093320A (es)
EP (1) EP0378432B1 (es)
JP (1) JPH02270895A (es)
CN (1) CN1031344C (es)
AT (1) ATE120758T1 (es)
AU (1) AU632526B2 (es)
CA (1) CA2008438A1 (es)
DE (1) DE69018275T2 (es)
DK (1) DK0378432T3 (es)
ES (1) ES2071004T3 (es)
HU (1) HU201964B (es)
IL (1) IL93107A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201964B (en) * 1989-01-13 1991-01-28 Richter Gedeon Vegyeszet Process for producing peptides inhibiting maturation of t-lymphocytes and activity of macrophages, as well as pharmaceutical compositions comprising same
EP0494248A4 (en) * 1989-09-29 1992-08-26 Rhone-Poulenc Rorer International (Holdings) Inc. Anti-thrombotic peptides and pseudopeptides
US5332726A (en) * 1989-09-29 1994-07-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic peptides and pseudopeptides
US6197529B1 (en) * 1990-11-21 2001-03-06 Torrey Pines Institute For Molecular Studies Linear substituted oligoalkyleneimine libraries
MX9201416A (es) * 1991-03-28 1992-10-01 Rhone Poulenc Rorer Int Peptidos y pseudopeptidos antitromboticos.
WO1995003067A1 (en) * 1993-07-21 1995-02-02 Khavinson Vladimir Khatskelevi Pharmaceutical with immunomodulating activity
FR2788058B1 (fr) * 1998-12-30 2002-01-25 Sederma Sa Compositions cosmetiques amincissantes
KR100464787B1 (ko) * 2002-03-20 2005-01-06 박용석 글루탐산염을 이용한 양전하 지질의 제조방법
CN107021996B (zh) * 2017-05-24 2020-02-14 中国海洋大学 一种短肽、其应用以及由其得到的抗菌组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
CA1157466A (en) * 1979-04-12 1983-11-22 Gideon Goldstein Peptides having thymopoietin-like activity
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
US4442031A (en) * 1981-10-15 1984-04-10 Hoffmann-La Roche Inc. Immunopotentiating peptides
US4395404A (en) * 1982-05-14 1983-07-26 George Washington University Synthetic thymosin β3 and β4 analogues
DE3421614A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von pentapeptiden mit wirkung auf das immunsystem und zwischenprodukte dieses verfahrens
AU602483B2 (en) * 1985-01-18 1990-10-18 Immunetech Pharmaceuticals Immunoregulatory peptides
HU201964B (en) * 1989-01-13 1991-01-28 Richter Gedeon Vegyeszet Process for producing peptides inhibiting maturation of t-lymphocytes and activity of macrophages, as well as pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
HU201964B (en) 1991-01-28
IL93107A0 (en) 1990-11-05
DE69018275D1 (de) 1995-05-11
CA2008438A1 (en) 1991-07-24
HUT53123A (en) 1990-09-28
AU4792290A (en) 1990-09-20
CN1044102A (zh) 1990-07-25
EP0378432A2 (en) 1990-07-18
ATE120758T1 (de) 1995-04-15
EP0378432A3 (en) 1991-04-24
JPH02270895A (ja) 1990-11-05
EP0378432B1 (en) 1995-04-05
DE69018275T2 (de) 1995-08-03
AU632526B2 (en) 1993-01-07
US5093320A (en) 1992-03-03
IL93107A (en) 1994-04-12
DK0378432T3 (da) 1995-05-01
CN1031344C (zh) 1996-03-20

Similar Documents

Publication Publication Date Title
EA200100749A1 (ru) Синтетические пептиды, обладающие поверхностной активностью, и их применение для приготовления синтетического сурфактанта
ES2051673T3 (es) Composiciones de fibra dietetica soluble de avena.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
MX9400166A (es) Microesferas de proteina vegetal, hidrolizada, modificada y metodos para su preparacion y su uso.
ES2177695T3 (es) Uso de derivados funcionales de la molecual de adhesion intercelular icam-1 en terapia antiviral.
GB2213823B (en) Synthetic peptides for use in the diagnosis and prevention of influenza virus infection
IT1244548B (it) Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
ES8800601A1 (es) Un procedimiento para preparar una formulacion farmaceutica liofilizada de activador de plasminogeno de tejidro (t-pa)
NO171296C (no) Kopling til aa forbinde slanger for medisinske formaal
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
DE3650733D1 (de) Pharmazeutische Zubereitungen und medizinische Verwendungen von Dioxopiperidinderivaten, insbesondere als Verstärker der Immunantwort sowie als antivirale und antibakterielle Wirkstoffe
IT8847871A0 (it) Ne e loro impiego come medicamenti derivati peptidici,loro preparazio-
UA27713C2 (uk) Амідинові похідні бензолу, що мають гіпоглікемічну активність, та їх фармацевтично прийнятні солі
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
DK627987A (da) Farmaceutiske praeparater
IT1203108B (it) Procedimento per la preparazione di derivati di dipertidi e relativi prodotti ad uso farmaceutico
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
EP0378432A3 (en) Novel peptides, their use to inhibit the maturation of t-lymphocytes and the activity of macrophages, and processes for their preparation
DK341489A (da) Fremgangsmaade til fremstilling af praeparater til anvendelse af biologiske aktive peptider til rektale og vaginale formaal
FI925518A0 (fi) Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi
ES2150034T3 (es) Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias.
IT8748235A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 378432

Country of ref document: ES